4.2 Article

Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

期刊

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
卷 20, 期 10, 页码 1064-1072

出版社

WILEY PERIODICALS, INC
DOI: 10.1002/pds.2228

关键词

asthma; inhaled corticosteroids; paediatric population; therapy adherence

向作者/读者索取更多资源

Aims Poor adherence with inhaled corticosteroids (ICSs) has been reported frequently and may be associated with uncontrolled asthma. A better understanding of factors influencing adherence may help to achieve higher adherence rates for a larger part of the population, which will eventually lead to better asthma control. The aim of this study was to investigate factors associated with adherence in paediatric ICS users. Methods We included 527 children using ICSs who participated in the Pharmacogenetics of Asthma Medication in Children: Medication with Anti-inflammatory Effects (PACMAN) cohort study. The outcome, a parent-reported adherence, was assessed by using the Medication Adherence Report Scale. Four categories of determinants were studied: child characteristics, family characteristics, medication use (parental beliefs towards medication; using Beliefs about Medicines Questionnaire) and environmental factors. Results Good adherence was observed in 302 children (57%). Increased fractional exhaled nitric oxide values (indication for airway inflammation) were associated with a lower chance of good adherence (OR=0.25, 95% CI=0.15-0.41). Parental necessity beliefs about medication were associated with higher adherence (OR=2.32, 95% CI=1.59-3.39). Dutch origin was also associated with higher adherence rates (OR=2.11, 95% CI=1.09-4.07). Furthermore, younger age (<6 years) was associated with better adherence (OR=1.62, 95% CI=1.02-2.59). Conclusions Increased airway inflammation was associated with lower ICS adherence, which underlines the need of good adherence to reach disease control. Our results suggest that by improving knowledge, especially in ethnic minorities, and by stimulating positive parental perception towards the nature of the disease, the characteristics of the prescribed drugs and the use of medications, better adherence and as a result better asthma control could be reached. Copyright (C) 2011 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Respiratory System

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial Lung disease

Catharina C. Moor, Judith C. Oppenheimer, Gizal Nakshbandi, Joachim G. J. V. Aerts, Paul Brinkman, Anke-Hilse Maitland-van der Zee, Marlies S. Wijsenbeek

Summary: Exhaled breath analysis using eNose technology shows promising results in accurately distinguishing between ILD patients and healthy controls, as well as different ILD subgroups. This noninvasive diagnostic tool could potentially be a novel biomarker for timely diagnosis in the future.

EUROPEAN RESPIRATORY JOURNAL (2021)

Letter Allergy

Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma

Mahmoud I. Abdel-Aziz, Nazanin Zounemat Kermani, Anne H. Neerincx, Susanne J. H. Vijverberg, Yike Guo, Peter Howarth, Sven-Erik Dahlen, Ratko Djukanovic, Peter J. Sterk, Aletta D. Kraneveld, Anke H. van der Zee, Kian Fan Chung, Ian M. Adcock

ALLERGY (2021)

Article Pharmacology & Pharmacy

Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens

Paola Nicoletti, Harshad Devarbhavi, Ashish Goel, Radha Venkatesan, Chundamannil E. Eapen, Jane Grove, Samreen Zafer, Einar Bjornsson, M. Isabel Lucena, Raul J. Andrade, Munir Pirmohamed, Mia Wadelius, Dominique Larrey, Anke-Hilse Maitland-van der Zee, Luisa Ibanez, Paul B. Watkins, Ann K. Daly, Guruprasad P. Aithal

Summary: HLA genotype has a small impact on TB drug-related DILI while the role of NAT2 gene is complex. NAT2*5 frequency is lower, and NAT2*6 and NAT2*7 are more common in cases, with homozygotes for NAT2*6 and/or NAT2*7 enriched among cases.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Allergy

Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma

Yusef Eamon Badi, Ana B. Pavel, Stelios Pavlidis, John H. Riley, Stewart Bates, Nazanin Zounemat Kermani, Richard Knowles, Johan Kolmert, Craig E. Wheelock, Sally Worsley, Mohib Uddin, Kjell Alving, Per S. Bakke, Annelie Behndig, Massimo Caruso, Pascal Chanez, Louise J. Fleming, Stephen J. Fowler, Urs Frey, Peter Howarth, Ildiko Horvath, Norbert Krug, Anke H. Maitland-van der Zee, Paolo Montuschi, Graham Roberts, Marek Sanak, Dominick E. Shaw, Florian Singer, Peter J. Sterk, Ratko Djukanovic, Sven-Eric Dahlen, Yi-Ke Guo, Kian Fan Chung, Emma Guttman-Yassky, Ian M. Adcock

Summary: The disease signature identified in atopic dermatitis (AD) can also be seen in adults with severe asthma, and the transcriptomic signature of AD patients who respond to anti-IL-22 therapy is enriched in severe asthma. The AD disease signature is enriched in the blood and sputum of patients with asthma and is correlated with the severity of asthma. The FZ-response signature is enriched in the blood and sputum of asthmatic patients and is correlated with the presence of neutrophils and mixed granulocytes in the sputum.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Respiratory System

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

Renate Kos, Paul Brinkman, Anne H. Neerincx, Tamara Paff, Marije G. Gerritsen, Ariana Lammers, Aletta D. Kraneveld, Harry G. M. Heijerman, Hettie M. Janssens, Jane C. Davies, Christof J. Majoor, Els J. Weersink, Peter J. Sterk, Eric G. Haarman, Lieuwe D. Bos, Anke H. Maitland-van der Zee

Summary: Targeted analysis of volatile organic compounds in exhaled breath can non-invasively identify patients with Pseudomonas aeruginosa in cystic fibrosis, with high accuracy. This provides a new approach for simplifying the diagnosis and monitoring of respiratory infections.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Respiratory System

Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis

Dominic Fenn, Mahmoud Abdel-Aziz, Paul Brinkman, Renate Kos, Anne H. Neerincx, Josje Altenburg, E. Weersink, Eric G. Haarman, Suzanne W. J. Terheggen-Lagro, Anke H. Maitland-van der Zee, Lieuwe D. J. Bos

Summary: Culture-independent analysis of cough swabs provides an inaccurate diagnosis of lower respiratory tract colonisation and should not be used as a diagnostic test in patients with CF.

JOURNAL OF CYSTIC FIBROSIS (2022)

Letter Allergy

Prediction of asthma in early preschool wheezing by electronic nose analysis

Niels Rutjes, Ivo van den Bongaardt, Simone Hashimoto, Peter Sterk, Wim Van Aalderen, Suzanne Terheggen-Lagro, Paul Brinkman, Anke-Hilse Maitland - van der Zee, Marc van der Schee, Eric Haarman

PEDIATRIC ALLERGY AND IMMUNOLOGY (2022)

Letter Allergy

Migration and allergic diseases: Findings from a population-based study in adults in Amsterdam, the Netherlands

Abena S. Amoah, Maria Prins, Elisabeth H. D. Bel, Wytske J. Fokkens, Aeilko H. Zwinderman, Maria Yazdanbakhsh, Anke H. Maitland-van der Zee, Ronald van Ree

ALLERGY (2022)

Review Health Care Sciences & Services

A Systematic Review of Chest Imaging Findings in Long COVID Patients

Somayeh Bazdar, Anastasia K. A. L. Kwee, Laura Houweling, Yolanda de Wit-van Wijck, Firdaus A. A. Mohamed Hoesein, George S. Downward, Esther J. Nossent, Anke H. Maitland-van der Zee

Summary: Long COVID refers to the persistence of COVID-19 symptoms after the initial infection, and it is associated with lung damage. This systematic review focuses on lung imaging and its findings in patients with long COVID. The study identified 31 articles that reported imaging findings of 342 long COVID patients, with computed tomography (CT) being the most common modality used. Various types of lung abnormalities were observed, but a significant proportion of patients had normal CT findings. Further research is needed to understand the role of lung and organ damage in long COVID.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Biochemistry & Molecular Biology

Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table

Feiko J. M. de Jong, Thijs T. Wingelaar, Paul Brinkman, Pieter-Jan A. M. van Ooij, Anke H. van der Zee, Markus W. Hollmann, Rob A. van Hulst

Summary: The study assessed whether VOCs in exhaled breath after COMEX-30 treatment are early markers of hyperoxic stress and/or POT. Results showed that the identified VOCs are associated with inflammatory responses or pulmonary diseases and most subjects reported pulmonary symptoms reflecting early-stage POT. Therefore, these VOCs are likely markers of POT, not just indicators of hyperbaric hyperoxic exposure.

METABOLITES (2023)

Article Biochemistry & Molecular Biology

Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

Mario Martin-Almeida, Javier Perez-Garcia, Esther Herrera-Luis, Carlos Rosa-Baez, Mario Gorenjak, Anne H. Neerincx, Olaia Sardon-Prado, Antoaneta A. Toncheva, Susanne Harner, Christine Wolff, Susanne Brandstetter, Elisa Valletta, Mahmoud Abdel-Aziz, Simone Hashimoto, Vojko Berce, Paula Corcuera-Elosegui, Javier Korta-Murua, Heike Buntrock-Doepke, Susanne J. H. Vijverberg, Joris C. Verster, Nikki Kerssemakers, Anna M. Hedman, Catarina Almqvist, Jesus Villar, Aletta D. Kraneveld, Uros Potocnik, Michael Kabesch, Anke H. Maitland-van der Zee, Maria Pino-Yanes

Summary: Asthma is a common chronic disease in children, but the influence of DNA methylation on bronchodilator drug response and fractional exhaled nitric oxide is understudied. In this study, we identified DNA methylation markers associated with fractional exhaled nitric oxide in blood samples and bronchodilator drug response in pediatric asthma patients.

BIOMEDICINES (2023)

Article Allergy

Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps

Korneliusz Golebski, Rik Johannes Leonardus van Der Lans, Danielle van Egmond, Esther de Groot, Hergen Spits, Anke-Hilse Maitland-van Der Zee, Cornelis Maria van Drunen, Wytske Johanna Fokkens, Sietze Reitsma

ALLERGY (2023)

Article Health Care Sciences & Services

Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension

Nadia Baalbaki, Jelle M. Blankestijn, Mahmoud I. Abdel-Aziz, Jan de Backer, Somayeh Bazdar, Ines Beekers, Rosanne J. H. C. G. Beijers, Joop P. van den Bergh, Lizan D. Bloemsma, Harm Jan Bogaard, Job J. M. H. van Bragt, Vera van den Brink, Jean Paul Charbonnier, Merel E. B. Cornelissen, Yennece Dagelet, Elin Haf Davies, Anne M. van der Does, George S. Downward, Cornelis M. van Drunen, Debbie Gach, J. J. Miranda Geelhoed, Jorrit Glastra, Kornel Golebski, Irene H. Heijink, Judith C. S. Holtjer, Sebastiaan Holverda, Laura Houweling, John J. L. Jacobs, Renee Jonker, Renate Kos, Ramon C. J. Langen, Ivo van der Lee, Asabi Leliveld, Firdaus A. A. Mohamed Hoesein, Anne H. Neerincx, Lieke Noij, Johan Olsson, Marianne van de Pol, Simon D. Pouwels, Emiel Rolink, Michael Rutgers, Havva Sahin, Daphne Schaminee, Annemie M. W. J. Schols, Lisanne Schuurman, Gitte Slingers, Olie Smeenk, Brigitte Sondermeijer, Paul J. Skipp, Marisca Tamarit, Inge Verkouter, Roel Vermeulen, Rianne de Vries, Els J. M. Weersink, Marco van de Werken, Yolanda de Wit-van Wijck, Stewart Young, Esther J. Nossent, Anke H. van der Zee

Summary: The P4O2 COVID-19 study aims to identify long COVID patients at risk for developing chronic lung disease and to find personalized therapeutic strategies. The study showed persistent symptoms and abnormalities in post-COVID patients, with the most commonly reported symptoms being respiratory and neurological symptoms.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Respiratory System

Biologicals in childhood severe asthma: the European PERMEABLE survey on the status quo

Elisangela Santos-Valente, Heike Buntrock-Dopke, Rola Abou Taam, Stefania Arasi, Arzu Bakirtas, Jaime Lozano Blasco, Klaus Bonnelykke, Mihai Craiu, Renato Cutrera, Antoine Deschildre, Basil Elnazir, Louise Fleming, Urs Frey, Monika Gappa, Antonio Nieto Garcia, Kirsten Skamstrup Hansen, Laurence Hanssens, Karina Jahnz-Rozyk, Milos Jesenak, Sebastian Kerzel, Matthias Kopp, Gerard H. Koppelman, Uros Krivec, Kenneth A. MacLeod, Mika Makela, Erik Melen, Gyorgyi Mezei, Alexander Moeller, Andre Moreira, Petr Pohunek, Predrag Minic, Niels W. P. Rutjes, Patrick Sammut, Nicolaus Schwerk, Zsolt Szepfalusi, Mirjana Turkalj, Iren Tzotcheva, Alexandru Ulmeanu, Stijn Verhulst, Paraskevi Xepapadaki, Jakob Niggel, Susanne Vijverberg, Anke H. Maitland-van der Zee, Uros Potocnik, Susanne M. Reinartz, Cornelis M. van Drunen, Michael Kabesch

Summary: The survey on biological therapy of childhood asthma in Europe revealed substantial differences in management across countries, indicating a need for further studies on biomarkers supporting selection of biologicals, criteria to assess therapy response, and how/when to end therapy in stable patients.

ERJ OPEN RESEARCH (2021)

Article Medicine, General & Internal

Inflammation and its associations with aortic stiffness, coronary artery disease and peripheral artery disease in different ethnic groups: The HELIUS Study

Charles F. Hayfron-Benjamin, Charlotte Mosterd, Anke H. Maitland-van der Zee, Daniel H. van Raalte, Albert G. B. Amoah, Charles Agyemang, Bert-Jan van den Born

Summary: This study found unequal associations between inflammatory biomarkers and vascular dysfunction in different ethnic groups, providing valuable insights for future research.

ECLINICALMEDICINE (2021)

暂无数据